George A. Fisher

机构：Stanford Medicine, Stanford University · ORCID：0000-0002-6828-3938

发表论文 357 篇 · 总被引 34130 次 · h-index 63

代表论文

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial (2025 · Nature Medicine · 被引 104)
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types (2024 · Journal for ImmunoTherapy of Cancer · 被引 54)
A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors (2025 · Targeted Oncology · 被引 26)
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma (2024 · Nature Communications · 被引 13)
10-year follow up of a phase 2 clinical trial of pembrolizumab (pembro) in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 7)
Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer (2024 · Annals of Surgery · 被引 5)